CRC surveillance in isolated colonic CD
What is the evidence for colonoscopic surveillance for CRC in patients with isolated colonic CD
What is known
- Crohn's colitis carries a CRC risk comparable to UC, and consensus guidelines extend UC-based surveillance to CD patients with ≥1/3 colonic involvement and ≥8 years of chronic colitis. 1,2
- The foundational Crohn's colitis surveillance series (259 patients) found dysplasia or cancer in 16%, underpinning current recommendations. 2
- A 2017 Cochrane systematic review linked colonoscopic surveillance to reduced CRC incidence and mortality, but rated evidence quality very low. 3
- A 2020 guideline reappraisal judged the primary evidence behind risk-factor categorisation highly variable and current US surveillance likely overly intensive for low-risk patients. 3
What is unknown / caveats
- Earlier cohort data questioned justifying surveillance for all extensive Crohn's colitis, favoring only long-standing young-onset disease 4
- 2020 reappraisal argues duration-based intervals miss some early cancers while over-surveilling low-risk patients 3
- No RCTs; evidence is case series, retrospective cohorts, and expert consensus
- Risk-factor categorisation confounded by variable control for inflammation and pre-biologic-era data
- Isolated colonic CD not separated from segmental/mixed phenotypes in most sources
- Whether isolated colonic CD specifically (vs Crohn's colitis broadly) warrants the same interval is not resolved by the retrieved evidence.
References
- Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(3):314-21. PMID: 15735438.
- Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis. 2009;15(4):630-8. PMID: 18942763.
- Shah SC, Itzkowitz SH. Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD. J Crohns Colitis. 2020;14(8):1172-1177. PMID: 32150256.
- Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35(11):1590-2. PMID: 7828978.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.
Sources retrieved: PMID 32150256 · PMID 15735438 · PMID 7828978 · PMID 18942763 · PMID 15352890 · PMID 17105691
answered 2026-08-04 · corpus build af433918 · faithfulness 0.7931034482758621
Reviewer notes